The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-(3-phenyl-isoxazol-5-yl)-1H-pyrimidine-2,4-dione ID: ALA2368958
Cas Number: 133070-83-4
PubChem CID: 5271257
Max Phase: Preclinical
Molecular Formula: C18H17N3O6
Molecular Weight: 371.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1-c1cc(-c2ccccc2)no1
Standard InChI: InChI=1S/C18H17N3O6/c22-9-15-13(23)7-16(26-15)21-8-11(17(24)19-18(21)25)14-6-12(20-27-14)10-4-2-1-3-5-10/h1-6,8,13,15-16,22-23H,7,9H2,(H,19,24,25)/t13-,15+,16+/m0/s1
Standard InChI Key: OMVJZCCMNRCBRW-NUEKZKHPSA-N
Molfile:
RDKit 2D
27 30 0 0 1 0 0 0 0 0999 V2000
1.6840 -3.7547 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9894 -4.3359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3484 -4.5083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8333 -5.1758 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1990 -3.0872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6538 -5.0895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5044 -3.6684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8099 -4.2496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3619 -4.8627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0293 -3.7067 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4540 -2.3026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3740 -3.0872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2224 -3.5351 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1156 -4.5272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7865 -1.8177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1191 -2.3026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5279 -4.5946 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1387 -5.7570 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8300 -4.9397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6655 -2.0477 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7865 -0.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0721 -0.5802 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8300 -5.7647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5445 -4.5272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2590 -4.9397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5445 -6.1772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2590 -5.7647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 7 2 0
3 1 1 0
4 3 1 0
5 1 1 1
6 2 1 0
7 1 1 0
8 2 1 0
9 8 2 0
10 13 1 0
11 5 1 0
5 12 1 0
13 8 1 0
14 9 1 0
15 11 1 0
16 12 1 0
17 3 2 0
18 6 2 0
19 14 1 0
16 20 1 6
15 21 1 1
22 21 1 0
23 19 2 0
24 19 1 0
25 24 2 0
26 23 1 0
27 25 1 0
4 6 1 0
15 16 1 0
10 14 2 0
27 26 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 371.35Molecular Weight (Monoisotopic): 371.1117AlogP: 0.50#Rotatable Bonds: 4Polar Surface Area: 130.58Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.49CX Basic pKa: ┄CX LogP: 0.47CX LogD: 0.47Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.61Np Likeness Score: -0.10
References 1. Wigerinck P, Snoeck R, Claes P, De Clercq E, Herdewijn P.. (1991) Synthesis and antiviral activity of 5-heteroaryl-substituted 2'-deoxyuridines., 34 (6): [PMID:2061920 ] [10.1021/jm00110a003 ]